Exact Mass: 1346.574862

Exact Mass Matches: 1346.574862

Found 11 metabolites which its exact mass value is equals to given mass value 1346.574862, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

hydroxocobalamin hydrochloride

hydroxocobalamin hydrochloride

C62H90CoN13O15P (1346.574862)


B - Blood and blood forming organs > B03 - Antianemic preparations > B03B - Vitamin b12 and folic acid > B03BA - Vitamin b12 (cyanocobalamin and analogues) V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes D006401 - Hematologic Agents > D006397 - Hematinics D018977 - Micronutrients > D014815 - Vitamins

   

Nickel(II)-5,9,14,18,23,27,32,36-octabutoxy-2,3-naphthalocyanine

Nickel(II)-5,9,14,18,23,27,32,36-octabutoxy-2,3-naphthalocyanine

C80H88N8NiO8 (1346.6078238)


   

Hydroxocobalamine

Hydroxocobalamine

C62H90CoN13O15P-2 (1346.574862)


B - Blood and blood forming organs > B03 - Antianemic preparations > B03B - Vitamin b12 and folic acid > B03BA - Vitamin b12 (cyanocobalamin and analogues) V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes D006401 - Hematologic Agents > D006397 - Hematinics D018977 - Micronutrients > D014815 - Vitamins

   

Vitamin B12a

Vitamin B12a

C62H90CoN13O15P-2 (1346.574862)


B - Blood and blood forming organs > B03 - Antianemic preparations > B03B - Vitamin b12 and folic acid > B03BA - Vitamin b12 (cyanocobalamin and analogues) V - Various > V03 - All other therapeutic products > V03A - All other therapeutic products > V03AB - Antidotes D006401 - Hematologic Agents > D006397 - Hematinics D018977 - Micronutrients > D014815 - Vitamins

   

Coalpha-[alpha-(2-methyladen-7-yl)]-Cobeta-methylcobamide

Coalpha-[alpha-(2-methyladen-7-yl)]-Cobeta-methylcobamide

C60H88CoN16O14P-3 (1346.5735197999998)


   
   

cobalt(2+);3-[(1R,2S,3S,5E,7S,8S,13S,14Z,17R,18R,19R)-2,7,18-tris(2-amino-2-oxoethyl)-17-[3-[[(2R)-2-[[(2R,3S,4R,5S)-5-(5,6-dimethyl-3H-benzimidazol-1-ium-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxypropyl]amino]-3-oxopropyl]-3,13-bis(3-imino-3-oxidopropyl)-1,2,5,7,12,12,15,17-octamethyl-3,8,13,18,19,22-hexahydrocorrin-8-yl]propanimidate;hydrate

cobalt(2+);3-[(1R,2S,3S,5E,7S,8S,13S,14Z,17R,18R,19R)-2,7,18-tris(2-amino-2-oxoethyl)-17-[3-[[(2R)-2-[[(2R,3S,4R,5S)-5-(5,6-dimethyl-3H-benzimidazol-1-ium-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy-hydroxyphosphoryl]oxypropyl]amino]-3-oxopropyl]-3,13-bis(3-imino-3-oxidopropyl)-1,2,5,7,12,12,15,17-octamethyl-3,8,13,18,19,22-hexahydrocorrin-8-yl]propanimidate;hydrate

C62H90CoN13O15P (1346.574862)


   
   

MSG606

MSG606

C62H82N20O13S (1346.6090642)


MSG606 is a selective MC1R (melanocortin 1 receptor) antagonist and can be used for the research of neuroprotective effects[1].

   

Terlipressin (diacetate)

Terlipressin (diacetate)

C56H82N16O19S2 (1346.5383302)


Terlipressin diacetate is a vasopressin analogue with potent vasoactive properties. Terlipressin diacetate is a highly selective vasopressin V1 receptor agonist that reduces the splanchnic blood flow and portal pressure and controls acute variceal bleeding. Terlipressin diacetate exerts anti-inflammatory and anti-oxidative effects. Terlipressin diacetate has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research[1][2][3][4][5].